Immunotherapy Making Headway in SCLC and Mesothelioma – OncLive
OncLive |
Immunotherapy Making Headway in SCLC and Mesothelioma
OncLive Immune-based therapies continue to show promising signals for patients with small cell lung cancer (SCLC) and mesothelioma, but better predictive biomarkers are needed to determine who is most likely to benefit, according to Justin F. Gainor, MD. The … |
